Is it possible to offer evidence-based treatment for systemic vasculitis?

The evidence base for treatment of systemic vasculitis is reviewed in this article. Accurate diagnosis and evaluation of disease status is crucial to the appropriate management of these cases and disease status should be employed as a means of staging so that appropriate therapy can be offered tailo...

Full description

Bibliographic Details
Main Author: Luqmani, R
Format: Journal article
Language:English
Published: 2000
_version_ 1797091360947306496
author Luqmani, R
author_facet Luqmani, R
author_sort Luqmani, R
collection OXFORD
description The evidence base for treatment of systemic vasculitis is reviewed in this article. Accurate diagnosis and evaluation of disease status is crucial to the appropriate management of these cases and disease status should be employed as a means of staging so that appropriate therapy can be offered tailored to the individual requirements of each case. Large vessel vasculitides are almost exclusively managed with corticosteroids. Small vessel vasculitis with internal organ involvement usually requires more aggressive immuno-suppression; by contrast, small vessel vasculitis without internal organ involvement rarely requires intervention. Despite our current efforts, the long-term morbidity of patients with systemic vasculitis remains high. We need better therapeutic strategies in order to limit or control disease rapidly and thereby prevent the accumulation of subsequent damage. Large-scale randomised trials comparing different therapeutic strategies offer the only hope of establishing a firmer evidence base for the optimal management of these diseases.
first_indexed 2024-03-07T03:31:54Z
format Journal article
id oxford-uuid:bb036870-e655-4c28-8a3d-c4941b6e57cb
institution University of Oxford
language English
last_indexed 2024-03-07T03:31:54Z
publishDate 2000
record_format dspace
spelling oxford-uuid:bb036870-e655-4c28-8a3d-c4941b6e57cb2022-03-27T05:13:53ZIs it possible to offer evidence-based treatment for systemic vasculitis?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bb036870-e655-4c28-8a3d-c4941b6e57cbEnglishSymplectic Elements at Oxford2000Luqmani, RThe evidence base for treatment of systemic vasculitis is reviewed in this article. Accurate diagnosis and evaluation of disease status is crucial to the appropriate management of these cases and disease status should be employed as a means of staging so that appropriate therapy can be offered tailored to the individual requirements of each case. Large vessel vasculitides are almost exclusively managed with corticosteroids. Small vessel vasculitis with internal organ involvement usually requires more aggressive immuno-suppression; by contrast, small vessel vasculitis without internal organ involvement rarely requires intervention. Despite our current efforts, the long-term morbidity of patients with systemic vasculitis remains high. We need better therapeutic strategies in order to limit or control disease rapidly and thereby prevent the accumulation of subsequent damage. Large-scale randomised trials comparing different therapeutic strategies offer the only hope of establishing a firmer evidence base for the optimal management of these diseases.
spellingShingle Luqmani, R
Is it possible to offer evidence-based treatment for systemic vasculitis?
title Is it possible to offer evidence-based treatment for systemic vasculitis?
title_full Is it possible to offer evidence-based treatment for systemic vasculitis?
title_fullStr Is it possible to offer evidence-based treatment for systemic vasculitis?
title_full_unstemmed Is it possible to offer evidence-based treatment for systemic vasculitis?
title_short Is it possible to offer evidence-based treatment for systemic vasculitis?
title_sort is it possible to offer evidence based treatment for systemic vasculitis
work_keys_str_mv AT luqmanir isitpossibletoofferevidencebasedtreatmentforsystemicvasculitis